Related Experiment Video
Updated: Jul 20, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Operating on the obese woman--A review
1Simpson Centre For Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, UK. claire.alexander@luht.scot.nhs.uk
BJOG : an International Journal of Obstetrics and Gynaecology
|September 16, 2006
Summary
Obesity increasingly complicates obstetrics and gynaecology. This review details strategies to reduce surgical complications for obese women during intrapartum and gynaecological procedures.
Area of Science:
- Obstetrics and Gynaecology
- Surgical Patient Care
Background:
- Growing prevalence of obesity presents significant challenges in obstetric and gynaecologic care.
- Obesity is linked to increased risks during surgical procedures in women.
Purpose of the Study:
- To review and highlight methods for reducing complications in intrapartum and gynaecological care for obese women.
- To discuss strategies for minimizing surgical morbidity in this patient population.
Main Methods:
- Literature review focusing on surgical management of obese patients in obstetrics and gynaecology.
- Analysis of techniques to mitigate risks associated with operating on obese individuals.
Main Results:
- Identification of key areas for complication reduction, including operative site selection and aseptic techniques.
- Emphasis on strategies to decrease postoperative complications in obese surgical patients.
Conclusions:
- Implementing specific surgical strategies can significantly reduce morbidity in obese women undergoing obstetric and gynaecologic procedures.
- Optimizing operative care is crucial for improving outcomes in this growing patient demographic.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...